Zenotech [ZENOTECH] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Zenotech Laboratories Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zenotech Laboratories Ltd. wins in 7 metrics, Gujarat Themis Biosyn Ltd. wins in 11 metrics, with 1 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zenotech Laboratories Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 82.73 73.73 Gujarat Themis Biosyn Ltd.
Price-to-Book Ratio 2.82 13.36 Zenotech Laboratories Ltd.
Debt-to-Equity Ratio 0.00 27.04 Tie
PEG Ratio 5.79 -17.55 Zenotech Laboratories Ltd.
EV/EBITDA 18.68 52.76 Zenotech Laboratories Ltd.
Profit Margin (TTM) 8.02% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 20.84% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 20.84% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 5.84% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 5.06% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $56.25M $-251.22M Zenotech Laboratories Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -29.00% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 6.62 22.23 Zenotech Laboratories Ltd.
Enterprise Value $2.50B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 5.97 22.65 Zenotech Laboratories Ltd.
Gross Profit Margin (TTM) 100.00% 83.29% Zenotech Laboratories Ltd.
Revenue per Share (TTM) $7 $15 Gujarat Themis Biosyn Ltd.
Earnings per Share (Diluted) $0.55 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.09 -0.17 Gujarat Themis Biosyn Ltd.

Zenotech Laboratories Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

ZENOTECH
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zenotech Laboratories Ltd.0.13%-1.28%1.39%-1.00%-8.38%-3.38%
Gujarat Themis Biosyn Ltd.1.72%7.42%6.10%33.40%-1.19%-10.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zenotech Laboratories Ltd.-29.00%-15.94%2.47%2.12%-12.79%-25.87%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Zenotech Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricZENOTECHGUJTHEM
Market Information
Market Cap i₹2.78B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,88179,452
90 Day Avg. Volume i17,746106,446
Last Close₹44.69₹401.80
52 Week Range₹33.55 - ₹67.00₹225.05 - ₹479.00
% from 52W High-33.30%-16.12%
All-Time High₹173.59 (Oct 01, 2007)₹479.00 (Oct 27, 2025)
% from All-Time High-74.26%-16.12%
Growth Metrics
Quarterly Revenue Growth0.16%0.10%
Quarterly Earnings Growth0.14%-0.04%
Financial Health
Profit Margin (TTM) i0.08%0.30%
Operating Margin (TTM) i0.21%0.40%
Return on Equity (TTM) i0.06%0.20%
Debt to Equity (MRQ) i0.0027.04
Cash & Liquidity
Book Value per Share (MRQ)₹16.11₹24.29
Cash per Share (MRQ)₹5.27₹0.92
Operating Cash Flow (TTM) i₹69.82M₹970.68M
Levered Free Cash Flow (TTM) i₹56.13M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Zenotech Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricZENOTECH (Apr 26, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i82.7373.73
Forward P/E iN/AN/A
PEG Ratio i5.79-17.55
Price to Sales (TTM) i6.6222.23
Price to Book (MRQ) i2.8213.36
Market Capitalization
Market Capitalization i₹2.78B₹35.41B
Enterprise Value i₹2.50B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i5.9722.65
Enterprise to EBITDA i18.6852.76
Risk & Other Metrics
Beta i0.09-0.17
Book Value per Share (MRQ) i₹16.11₹24.29

Financial Statements Comparison: Zenotech Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZENOTECH (2025)GUJTHEM (2025)
Revenue/Sales i389.76M1.51B
Cost of Goods Sold i52.64M318.78M
COGS % of Revenue i13.5%21.1%
Gross Profit i337.11M1.19B
Gross Margin i86.5%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i31.79M642.49M
Operating Margin i8.2%42.6%
EBITDA i157.24M713.04M
EBITDA Margin i40.3%47.3%
Pre-Tax Income i106.92M655.38M
Pre-Tax Income % of Revenue i27.4%43.5%
Income Tax i50.79M167.66M
Income Tax % of Revenue i13.0%11.1%
Net Income (Profit) i56.13M487.72M
Profit Margin i14.4%32.3%

Balance Sheet & Liquidity Metrics

MetricZENOTECH (2025)GUJTHEM (2025)
Cash & Equivalents i265.75M116.94M
Total Current Assets i359.89M519.73M
Total Current Assets % of Revenue i92.3%34.5%
Total Current Liabilities i125.87M205.60M
Total Current Liabilities % of Revenue i32.3%13.6%
Long-Term Debt i0296.36M
Long-Term Debt % of Revenue i0.0%19.7%
Total Shareholders Equity i961.31M2.48B
Retained Earnings i-1.74B2.37B
Retained Earnings % of Revenue i-447.6%157.4%
Property, Plant & Equipment i22.30M411.30M

Cash Flow Statement Comparison

MetricZENOTECH (2025)GUJTHEM (2025)
Operating Cash Flow i69.82M970.68M
Operating Cash Flow % of Revenue i17.9%64.4%
Capital Expenditures i-38.63M-1.16B
Free Cash Flow i56.25M-251.22M
FCF Margin i14.4%-16.7%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricZENOTECHGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i61.03M108.97M
Float Shares i11.70M29.52M
% Held by Insiders i84.53%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i15.47%26.84%

Dividend Analysis & Yield Comparison: Zenotech Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricZENOTECHGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025